Carregant...
Felbamate add‐on therapy for drug‐resistant focal epilepsy
BACKGROUND: This is an updated version of the Cochrane Review previously published in 2017. Epilepsy is a chronic and disabling neurological disorder, affecting approximately 1% of the population. Up to 30% of people with epilepsy have seizures that are resistant to currently available antiepileptic...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2019
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6699672/ https://ncbi.nlm.nih.gov/pubmed/31425617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008295.pub5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|